geneflux™ biosciences

http://www.geneflux.net.myhttp://www.geneflux.net.my

(ISO9001:2008 Certified Company)(ISO17025:2005 Accreditated

(ISO13485:2003 Certified laboratory facility)

Frost & Sullivan Award -2010, for the Niche company in Molecular Diagnostics in Asia Pacific Region

Frost & Sullivan Award -2012, for the Southeast Asia Fastest Growing Company in Molecular Diagnostics

for Infectious Disease

04/22/23 1

Geneflux - backgroundGeneflux™ Biosciences Sdn. Bhd. is a privately held,

research and technology driven biotechnology and molecular diagnostics company specialized in the manufacture of molecular diagnostic kits and providing services to healthcare industry.

Establishment: in the year 2007 in Malaysia and IndiaBioNexus Status Company Award: June 2008Geneflux™ Diagnostics Sdn. Bhd. is a wholly owned

subsidiary of Geneflux Biosciences, dedicated to provide molecular diagnostic services in Malaysia.

Establishment: in the year 2009 in Malaysia04/22/23 2

ManagementBoard of Directors

Ir.Balaguru Naidu, Director & CEODr.Prashanth G.Bagali, Director & COO, SVPMr. Azlan bin Baharom, DirectorMr. Mohammad Abdul Samad, Director

Business & Organizational LeadersIr.Balaguru Naidu, CEODr.Prashanth G.Bagali, COO & SVP-Sci. and Tech.

04/22/23 3

Company dataAuthorized capital: RM500,000.00Issued capital: RM425,000.00Company #: 769382-V; Registration: April 13, 2007Registered address: 7-3 block ), Jalan Selingsing 3, Taman

Sri Kuching, 51200, Kuala Lumpur, MalaysiaBusiness address: G1&G2, Menara KLH, Bandar Puchong

Jaya, 47100 Puchong, Selangor DE, MalaysiaTelephone; +60-3-80701154; Fax: +60-3-80703654Email: info@geneflux.net.my, pgbagali@geneflux.net.my

04/22/23 4

Certification & registrationsBioNexus Status Company Award: June 2008

Certification under Malaysian Biotechnology CorporationAchievement under Technofund scheme Ministry of Science, Technology and

Innovation (MOSTI) – project grant and AwardFrost & Sullivan Award -2010, for the Niche company in Molecular Diagnostics

in Asia Pacific Region Frost & Sullivan Award -2012, for the Southeast Asia Fastest Growing

Company in Molecular Diagnostics for Infectious Disease Certification of ISO9001:2008Certification of ISO13485:2003Accreditation of ISO17025:2005 RCPA Quality Assurance Program, Australia Institute of Medical Research (IMR) Internal Quality Assessment Scheme,

MalaysiaRegistrations: MOF, MITI, MATRDE

04/22/23 5

Global Presence*Geneflux Biosciences Private Limited, Bangalore*Geneflux Diagnostics Limited, London*Geneflux Biodiagnostics LLC, Detroit (USA)

Total Staff: 19Science & Technology division: 8Admin, HR & Support Division: 5Sales, Marketing and Customer Support: 2Logistics and Operations Division: 4

* = independent companies04/22/23 6

Science & Technology teamPrashanth Bagali, PhD (Genetics), PhD (Biotech),PDF (NIH-

NIDDK, USA)Geetha Subramaniam, PhD (Med.Microbiology)Parimala, BS (Biomedicine)Pathma, BS (Biomedicine)Ketan Kumar, BE (biotechnology)Erwina [B.S (1st year ) in Biotechnology]Nurfasha [B.S (1st year) in Biotechnology]Lab. AssistantsLab. Technicians

04/22/23 7

SCIENCE & TECHNOLOGY

Molecular Diagnostics Services Research

VirusesViruses BacteriaBacteria TechnologiesTechnologies

PCR Technology

2D & 3D Gels analysis

Protein Profiling

Contract Research

Product Development

Training

PRODUCTS AND SERVICES

Product validation

Microarray Projects

04/22/23 8

Core TechnologiesNucleic acid (DNA and RNA) based tests

Polymerase chain reaction (PCR)Real time reverse transcriptase PCR (RT-PCR)

Microbiology lab testsELISA based testsRapid Antigen Tests

04/22/23 9

Core Business1. Manufacturing of molecular diagnostic kits2. Providing diagnostic services to private and public

hospitals, clinics and medical centres

Geneflux Diagnostics Sdn. Bhd. is the wholly owned subsidiary of Geneflux Biosciences Sdn Bhd.

Directors / shareholders:1. Ir.Balaguru Naidu2. Dr.Prashanth G.Bagali

04/22/23 10

Diagnostics LaboratoryISO9001:2008 certified quality management systemISO17025:2005 (accreditation for “laboratory quality and proficiency ”)ISO13485:2003 design, manufacturing and production of molecular

diagnostic test kits and providing diagnostic services

4000 sq.ft built-in areaVery well equipped to handle 1000 samples for PCR analysis everydayStatutory and regulatory compliance to Biosafety and clinical waste

disposal Work bench capacity: simultaneously 14 persons can workTotal investment: 2.5 million ringgits (approx. US$750,000)

04/22/23 11

Diagnostics Laboratory (contd…)Highlights1. Five room concept:

Sample processing room Pre-PCR room Post-PCR room Lab bench room Decontamination / instrument room: Ice maker, freezers,

MilliQ water purification system, incubators, wash area

04/22/23 12

Diagnostics Laboratory (contd…)Molecular biology equipments1. PCR machines (Biorad, Eppendorf, Qiagen) : 2 conventional

PCR, 3 real time PCR2. Class II biological safety cabinets: 23. Freezers / fridges (Sanyo, Toshiba, Hitachi, Haier): 54. MilliQ water purification system5. Gel documentation (Alpha Imager): 16. Centrifuges –minicentrifuges, high speed: 47. Concentrator, autoclave, Ice maker and incubators8. Others: Thermomixer, electrophoresis units, PCR

workstations, ductless fume cabinet

04/22/23 13

Collaborations - R & DResearch collaborators:

1. University of Malaya (UM)2. Universiti Putra Malaysia (UPM)3. Universiti Kebangsaan Malaysia (UKM)4. University Technology Petronas (UTP)5. Universiti Sains Malaysia (USM)6. Malaysian Palm Oil Board (MPOB)

Patents / Innovation / Licenses: 4 Licenses

04/22/23 14

Market Need and demand

04/22/23 15

Business strategy1. Franchising2. Scaling up of business operation3. Acquisition 4. Strategic Alliance

04/22/23 16

Investment for business expansion1. Pathology Services (a) PCR tests: New tests will be included to the existing list of PCR

tests (b) Genetic tests: Existing list of tests. Dedicated team of Sales executives for building awareness in other states outside KL and Selangor. (c) Microarray and Next generation based sequencing based

diagnostic tests (d) Business relationship with IMR, HKL, Sungai Buloh Hospital and National Public Health to increase inflow of samples with a "unique profit sharing strategy".

04/22/23 17

Investment for business expansion (contd.)2. Clinical Research Services (a) CRO (Contract Research Outsourcing) to biotech and

pharmaceutical companies (b) Analytical services customized to specific requirement

04/22/23 18

Investment for business expansion (contd.)

(3) Wellness Centre- based on the concept of predictive, preventive and personalized medicine. (a) Individual offerings: Examples are Age wise tests for wellness, Gender based test package, Smoker panels, Drug and alcohol rehab tests, (b) Corporate Offerings: Pre-employment packages, Annual health

checkups (c) Occupational Health offerings

04/22/23 19

Investment for business expansion (contd.)(4) Centre of Excellence (CoE) will participate in national and international quality assurance programs and schemes; to become National Reference Laboratory (a) CoE for Microbiology (b) CoE for Molecular Pathology (c) CoE for Cancer in collaboration with Merck or Roche or

AstraZenaca or Sanofi Pharma to popularize Companion Diagnostics

04/22/23 20

Investment for business expansion (contd.)(5) Research and Development (a) Medical Biotechnology with specific focus on diabetes, cancer, CVD and others (b) Agricultural Biotechnology with specific focus on medicinal plants (6) Dental pulp stem cell banking:

04/22/23 21

Products & ServicesGeneflux™ conventional PCR and RT-PCR based kits

1. MyDENKit™, detection and serotyping of dengue virus using SybrGreen probe based real time PCR

2. Chikungunya detection kit (lab use only) using conventional PCR

3. MuRSAFlux ™, identification of Methicillin resistance staphylococcus aureus (lab use only)

4. FluFinder-detection of H1N1 virus (lab use only)

04/22/23 22

04/22/23 23

There is great market need and demand for PCR tests and opportunity in both public and private sectors. Geneflux has the technological expertise and right team to provide solution within the best TAT (turn around time) and at affordable price.

There is money to be made!!!!

04/22/23 24

At your serviceThank You

04/22/23 25

1. Sample Receiving ROOM

2.Pre-PCR room

3.Post PCR room